Literature DB >> 1007897

Bismuth encephalopathy.

G Monseu, M Struelens, M Roland.   

Abstract

Bismuth encephalopathy, characterized by the constant association of acute confusion, myoclonus, severe ataxia and dysarthia has reached "epidemic" proportion since its first description in 1974. The clinical aspects the pathogenic hypothesis, the diagnostic criteria as well as the report of a typical case are described by the authors, who stress the similarities with encephalopathies induced by other metals.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1007897

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  4 in total

1.  Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.

Authors:  P R Froomes; A T Wan; A C Keech; J J McNeil; A J McLean
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.

Authors:  Estelle Guiard; Bénédicte Lelievre; Magali Rouyer; Frank Zerbib; Bertrand Diquet; Francis Mégraud; François Tison; Emmanuelle Bignon; Régis Lassalle; Cécile Droz-Perroteau; Nicholas Moore; Patrick Blin
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

Review 3.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.